Pediatric acute stroke alert in Nantes and Angers hospitals: description of patients included and comparison with published data [0.03%]
南特和安_GEN缺失_尔医院的儿科急性脑卒中预警：纳入患者的特征及与已发表数据的比较
Floriane Le Bricquir,Sophie Gueden,Didier Loisel et al.
Floriane Le Bricquir et al.
Objective: This study aimed to describe data of patients included in the in-hospital pediatric stroke alert and compare it to published data. Methods: ...
Impact of the francophone pediatric intensive care group bronchiolitis recommendations on diagnostic testing, antibiotic therapy and patient prognosis [0.03%]
法语儿童重症监护小组支气管炎推荐意见对诊断检查、抗生素治疗和患者预后的影响
Pauline Labe,Matthieu Bendavid,Julie Toubiana et al.
Pauline Labe et al.
Background: Acute bronchiolitis is a common viral infection in infants, with severe cases requiring admission to pediatric intensive care units (PICU). While bacterial co-infections are rare, timely diagnosis and manageme...
Genetic counseling, prenatal diagnosis and newborn screening in Duchenne muscular dystrophy [0.03%]
杜氏肌营养不良的遗传咨询、产前诊断和新生儿筛查
France Leturcq,Camille Verebi,Juliette Nectoux
France Leturcq
Genetic counseling is a communication process in which qualified professionals help individuals to understand and consider the medical, psychosocial, and family implications of a disease. In the case of Duchenne muscular dystrophy (DMD), a ...
Helge Amthor
Helge Amthor
Over the past three decades, new therapeutic strategies have been developed to treat Duchenne muscular dystrophy (DMD). These strategies aim to correct the primary genetic defect, compensate for secondary pathological changes resulting from...
V Laugel
V Laugel
Duchenne muscular dystrophy (DMD) is a severe X-linked myopathy caused by mutations in the DMD gene, resulting in the absence of functional dystrophin. Gene therapy seems to represent a rational therapeutic strategy, aiming to restore dystr...
Stéphanie Fontaine-Carbonnel
Stéphanie Fontaine-Carbonnel
Duchenne muscular dystrophy (DMD) is a severe degenerative disease that remains incurable. Its prognosis has been transformed by multidisciplinary care, which has significantly improved the life expectancy of patients. Corticosteroids have ...
Neuropsychological management in Duchenne muscular dystrophy: A critical overview and future directions [0.03%]
杜氏肌营养不良症的神经心理管理：批判性概述与未来方向
Nathalie Angeard
Nathalie Angeard
Pediatric neuromuscular disorders constitute a highly heterogeneous group of over 200 distinct conditions, varying in etiology, affected structures (e.g., peripheral motor neurons, neuromuscular junction, or muscle tissue), central nervous ...
Mathilde Gaumé,Vincent Cunin,Carole Vuillerot
Mathilde Gaumé
This article provides a comprehensive overview of the orthopedic management strategies in Duchenne muscular dystrophy (DMD). DMD manifests with severe muscle wasting, respiratory insufficiency, and cardiomyopathy, with initial symptoms emer...
Helge Amthor,Aurélie Avril,France Leturcq
Helge Amthor
Duchenne muscular dystrophy (DMD) is a severe X-linked recessive disorder caused by mutations in the DMD gene located on the Xp21.2-Xp21.1 region of the X chromosome. This gene encodes dystrophin, a cytoskeletal protein that is critical for...
Hélène Prigent
Hélène Prigent
Respiratory complications are amajor cause of morbidity and mortality in Duchenne muscular dystrophy (DMD). Progressive weakness of inspiratory and expiratory muscles leads to ineffective cough, mucus retention, sleep-disordered breathing, ...